Laboratory analyses used to screen for and diagnose celiac disease produce numerical values that fall within established parameters. For example, tissue transglutaminase IgA (tTG-IgA) antibody levels are often assessed, with different thresholds indicating negative, weakly positive, or strongly positive results. These quantitative values, along with qualitative observations from small intestinal biopsies where applicable, help clinicians determine the likelihood of celiac disease.
Understanding the expected values for these tests allows healthcare professionals to accurately interpret individual patient data, differentiating between positive, negative, and equivocal findings. This clarity is crucial for timely diagnosis and initiation of appropriate management, preventing long-term complications associated with untreated celiac disease. The development and refinement of these laboratory tests have significantly improved diagnostic capabilities compared to older, less reliable methods.
